22nd Century Group, Inc. (XXII)

22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributing Company to Place VLN® in Thousands of Retail Locations Across Colorado

View Press Release View All

Sep 13, 2022 • 9:30 AM EDT

22nd Century Group’s (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden’s Cancer Moonshot Initiative

View Press Release

Sep 12, 2022 • 4:05 PM EDT

22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board

View Press Release

Sep 7, 2022 • 4:45 PM EDT

22nd Century Group (Nasdaq: XXII) Announces Management Updates and Departure of Chief Operating Officer

View Press Release